Global Migraine Market: Industry Analysis & Outlook (2018-2022)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 75
Inquire Before Buying

Migraine is a chronic neurologic disease characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others.

Migraine headache is typically throbbing, unilateral (one sided), and is aggravated by physical activity. It typically presents with additional symptoms in addition to headache pain, including nausea, and sensitivity to light and/or sound.

Depending on symptoms, migraine is broadly classified into two categories, Chronic and Episodic. Migraines can be treated with two types of drugs: pain-relieving and preventive. Pain-relieving medications are especially useful for people who have nausea or vomiting related to their migraine, and they work quickly. Preventive treatment is considered if migraine occurs frequently, typically more than one migraine per week, or if migraine symptoms are severe.

The global migraine market is expected to grow in future due to increasing female population, rising health expenditure, accelerating economic growth, increasing cigarette consumption, rising prevalence of migraine and unmet needs. Key trends of this market include development of migraine drugs and growing awareness regarding migraine and its treatments. However, there are some factors which can hinder the growth of migraine market which includes regulatory challenges, high cost, adverse effects of drugs, lack of proper diagnosis and increased preference of alternative therapies.

The report “Global Migraine Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, with focus majorly on the U.S. market. The report profiles the key players of the market including Amgen Inc., Eli Lilly and Company, Teva Pharmaceuticals & Alder Biopharmaceuticals.

Global Migraine Market: Industry Analysis & Outlook (2018-2022)

Table of Contents

1. Overview
1.1 Introduction
1.2 Types
1.3 Stages
1.4 Diagnosis
1.5 Treatment

2. Global Market Analysis
2.1 Global Migraine Market by Value
2.2 Global Migraine Market Forecast by Value
2.3 Global Migraine Market by Drug Type
2.4 Global Therapeutic Botulinum Toxin Market Forecast by Value
2.5 Global Therapeutic Botulinum Toxin Market by Indication

3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Migraine Population Forecast
3.1.2 The U.S. Diagnosed & Treated Adult Migraine Population
3.1.3 The U.S. Migraine Population with CV Risk Factors
3.1.4 The U.S. Migraine Treatment by Specialty
3.1.5 The U.S. Migraine Treated Population by Drug Type
3.1.6 The U.S. Acute Migraine Prescription Volume
3.1.7 The U.S. Migraine Prophylaxis Market by Treatment
3.2 The U.S. Migraine Drugs Revenue
3.2.1 The U.S. Botox Migraine Revenue and Treated Patients
3.2.2 The U.S. Cambia Drug Revenue
3.2.3 The U.S. Lasmiditan Drug Revenue & Treated Patients
3.2.4 The U.S. Alder Drug Revenue
3.2.5 The U.S. Erenumab Drug Revenue and Treated Patients
3.2.6 The U.S. Galcanezumab Drug Revenue and Treated Patients
3.2.7 The U.S. Fremanezumab Drug Revenue and Treated Patients
3.3 Europe
3.3.1 Europe Total Migraine and Diagnosed Population
3.4 Europe Migraine Drug Revenue
3.4.1 Europe Alder Drug Revenue

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Female Population
4.1.2 Increasing Cigarette Consumption
4.1.3 Accelerating Economic Growth
4.1.4 Increasing Healthcare Spending
4.1.5 Rising Prevalence of Migraine Cases
4.1.6 Unmet Needs
4.2 Key Trends & Development
4.2.1 Migraine Drugs under Development
4.2.2 Growing Awareness for Migraine
4.3 Challenges
4.3.1 Adverse Effects of Drugs
4.3.2 Lack of Proper Diagnosis
4.3.3 Increased Preference for Alternative Therapies
4.3.4 Regulatory Challenges
4.3.5 High Cost Associated

5. Competition
5.1 Global Market
5.1.1 Global Migraine Market- Revenue Comparison of Key Companies
5.1.2 Global Migraine Market- Market Cap Comparison of Key Companies
5.1.3 Global Migraine Market- R&D Comparison of Key Companies

6. Company Profiles
6.1 Amgen Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Eli Lilly and Company
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Teva Pharmaceuticals
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Alder Biopharmaceuticals
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Tables

Difference between Episodic and Chronic Migraine
Stages of Migraine
Migraine Drugs under Development (2017)
Alder Pharmaceuticals Pipeline Overview (2017)

List of Charts

Types of Migraine
Global Migraine Market by Value (2013-2017)
Global Migraine Market Forecast by Value (2018-2022)
Global Migraine Market by Drug Type (2017)
Global Therapeutic Botulinum Toxin Market Forecast by Value (2017-2022)
Global Therapeutic Botulinum Toxin Market by Indication (2017)
The U.S. Migraine Population Forecast (2017-2022)
The U.S. Diagnosed and Treated Adult Migraine Population (2017-2022)
The U.S. Migraine Population with CV Risk Factors (2017-2022)
The U.S. Migraine Treatment by Specialty (2017)
The U.S. Migraine Treated Population by Drug Type (2017)
The U.S. Acute Migraine Prescription Volume (2017-2022)
The U.S. Migraine Prophylaxis Market by Treatment (2017)
The U.S. Botox Migraine Revenue and Treated Patients (2017-2022)
The U.S. Cambia Drug Revenue (2017-2022)
The U.S. Lasmiditan Drug Revenue & Treated Patients (2018-2022)
The U.S. Alder Drug Revenue (2019-2024)
The U.S. Erenumab Drug Revenue and Treated Patients (2018-2022)
The U.S. Galcanezumab Drug Revenue and Treated Patients (2019-2024)
The U.S. Fremanezumab Drug Revenue and Treated Patients (2019-2024)
Europe Total Migraine and Diagnosed Population (2017-2022)
Europe Alder Drug Revenue (2021-2026)
Global Female Population (2013-2017)
Global Cigarette Consumption (2014-2017)
Global GDP Per Capita (2013-2017)
Global Healthcare Spending Per Capita (2013-2017)
Global Migraine Market-Revenue Comparison of Key Companies (2017)
Global Migraine Market- Market Cap Comparison of Key Companies (2017)
Global Migraine Market- R&D Comparison of Key Companies (2017)
Amgen Inc. Revenue by Geographic Region (2017)
Amgen Inc. Revenue and Net Income (2013-2017)
Amgen Inc. Research and Development Expenditure (2015-2017)
Eli Lilly and Company Revenue by Segments (2017)
Eli Lilly and Company Revenue and Net Income (2013-2017)
Eli Lilly and Company Research and Development Expenditure (2015-2017)
Teva Pharmaceuticals Revenue by Segments (2017)
Teva Pharmaceuticals Revenue and Net Income (2013-2017)
Alder Biopharmaceuticals Revenue and Net Income (2013-2017)
Alder Biopharmaceuticals Research & Development Expenditure (2015-2017)

  • Global Adult Cooling Sheet Market Insights, Forecast to 2025
    Published: 18-Dec-2018        Price: US 3900 Onwards        Pages: 111
    In 2017, the global Adult Cooling Sheet market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Adult Cooling Sheet market based on company, product type, application and key regions. This report studies the global market size of Adult Cooling Sheet in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focu......
  • Global Baby Cooling Sheet Market Insights, Forecast to 2025
    Published: 18-Dec-2018        Price: US 3900 Onwards        Pages: 113
    In 2017, the global Baby Cooling Sheet market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Baby Cooling Sheet market based on company, product type, application and key regions. This report studies the global market size of Baby Cooling Sheet in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses......
  • Global Microneedle Drug Delivery Systems Market Professional Survey Report 2018
    Published: 18-Dec-2018        Price: US 3500 Onwards        Pages: 147
    This report studies the global Microneedle Drug Delivery Systems market status and forecast, categorizes the global Microneedle Drug Delivery Systems market size by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, China, Japan, Southeast Asia, India and ROW. Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing......
  • Global Cooling Sheet Market Insights, Forecast to 2025
    Published: 18-Dec-2018        Price: US 3900 Onwards        Pages: 116
    In 2017, the global Cooling Sheet market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Cooling Sheet market based on company, product type, application and key regions. This report studies the global market size of Cooling Sheet in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consump......
  • Global Polygeline Injection Market Insights, Forecast to 2025
    Published: 18-Dec-2018        Price: US 3900 Onwards        Pages: 119
    In 2017, the global Polygeline Injection market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Polygeline Injection market based on company, product type, application and key regions. This report studies the global market size of Polygeline Injection in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, f......
  • Global Gelatin Polypeptide Plasma Expander Market Insights, Forecast to 2025
    Published: 18-Dec-2018        Price: US 3900 Onwards        Pages: 119
    In 2017, the global Gelatin Polypeptide Plasma Expander market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Gelatin Polypeptide Plasma Expander market based on company, product type, application and key regions. This report studies the global market size of Gelatin Polypeptide Plasma Expander in key regions like North America, Europe, Asia Pacific, Centra......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Consumer Healthcare Market 2018, Forecast to 2023
    Published: 18-Dec-2018        Price: US 4880 Onwards        Pages: 145
    Consumer healthcare products include trusted brands of multivitamins and iron supplements, in addition to products for allergies, personal hygiene, sleep support, alertness and cold and flu. Scope of the Report: This report focuses on the Consumer Healthcare in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Consumer he......
  • Global Erwinia L-Asparaginase Market Insights, Forecast to 2025
    Published: 18-Dec-2018        Price: US 3900 Onwards        Pages: 115
    Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. The global Erwinia L-Asparaginase market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment,......
  • Global Erwinia L-Asparaginase Drugs Market Insights, Forecast to 2025
    Published: 18-Dec-2018        Price: US 3900 Onwards        Pages: 116
    Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. The global Erwinia L-Asparaginase Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, se......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs